U.S. Backs Waiving Intellectual Property Rights On Vaccines

The US has decided to waive intellectual property rules on vaccines to expedite global access. US Trade Representative Katherine Tai emphasized the need for extraordinary measures during these times. The World Trade Organization has been debating this idea, with supporters arguing it will save lives by increasing vaccine availability in developing countries. However, critics doubt its impact and express concerns about future research control. The World Health Organization praised the US decision as a strong leadership example.

What was the primary goal of the US decision to waive intellectual property rules on vaccines?

• To enhance research control for companies

• To increase vaccine prices

• To speed up global access to vaccine doses

• To limit vaccine distribution to certain countries

Who stated that extraordinary times call for extraordinary measures in the context of vaccine IP waivers?

• The director general of the World Health Organization

• A spokesperson from the World Trade Organization

• A representative from a pharmaceutical company

• US trade representative Katherine Tai

What is the main argument of those supporting the removal of IP protections on vaccines?

• It will lead to more research control for companies

• It will help developing countries access more doses

• It will reduce the quality of vaccines

• It will increase vaccine prices

What concern do critics have about waiving IP protections on vaccines?

• It will lead to more government control over companies

• It will enhance global cooperation

• It might not have a major impact on vaccine access

• It will significantly increase vaccine production

How did the World Health Organization respond to the US decision on vaccine IP waivers?

• They suggested alternative measures

• They praised it as a powerful example of leadership

• They remained neutral

• They criticized the decision